Title: Drug Delivery System and Nano Technology

Biography:

Dr. Saharan has MS in Life Sciences (JNU); Ph.D in medicine (WVU) & Post Doc. (Stanford University).He has several International Publications / Presentations including in Top Scientific Journal Nature from the age of 21.

Nominated for several Global Awards including by New Drug Discovery Programme of Department of Science & Technology (GoI) funded US$ 3 million grant and the best US Scientist Award at age 22 years by AAAS, Washington DC. Dr. Pawan Saharan has been CSO & CEO for large MNC & founder of Biomix Network Inc. USA & India.

Dr. Saharan has global experience in running healthcare industry, including the Pharmaceuticals MNCs and hospitals at the top management level in USA & India

Abstract

Pawan Saharan has invented Radha108 Nano Peptides that naturally producing new generation antibodies & their  bio similar like Cytokine (Interleukin & Interferon)  by Secretion from Cytotoxic T- cells   of the innate immune system, which was increased by  5 times  due to RADHA 108 Nano Peptide that get absorbed in the blood through buccal mucosa & crosses the Blood Brain Barrier.

Radha108  act on pituitary gland that in turn promotes differentiation of B cells, maturation of macrophages and monocytes & Stimulates production of cytokines IL-1 to IL-11, TNF-α, INF–γ & maturation of immature thymocytes into either helper or suppressor T cells that helps building body's immune system strongly to fight any infection and immune disorders like Asthma, Allergy, URTI, Carcinomas and Type 2 diabetes saving hundreds  of Billions of $ that are spent in treating such ailments with little or no efficacy.

The mode of action of Receptol® is based on API Radha 108 Nano-informational peptides proteins which are active in mitigating cell fusion & docks on Gp120, 180, 160 receptor CD4, CD8 on the cell surface closing entry of virus like foreign antigen and allergens. Radha108 functions as a molecular signaling device which works through receptors on target cell surfaces.